Radioimmunotherapy of solid tumors: the promise of pretargeting strategies using bispecific antibodies and radiolabeled haptens.
Reilly
Raymond M
RM
University of Toronto Toronto, Ontario, Canada. raymond.reilly@utoronto.ca
D018033:Antibodies, Bispecific / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D016503:Drug Delivery Systems / Q000379:methods*; D006241:Haptens / Q000627:therapeutic use*; D006801:Humans; D007553:Isotope Labeling / Q000379:methods; D009369:Neoplasms / Q000532:radiotherapy*; D010818:Practice Patterns, Physicians' / Q000639:trends; D016499:Radioimmunotherapy / Q000379:methods* / Q000639:trends*; D011868:Radioisotopes / Q000627:therapeutic use*; D019275:Radiopharmaceuticals
D018033:Antibodies, Bispecific; D000911:Antibodies, Monoclonal; D006241:Haptens; D011868:Radioisotopes; D019275:Radiopharmaceuticals